Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial.
BACKGROUND: Malaria in pregnancy is associated with maternal and fetal morbidity and mortality. In 2006, WHO recommended use of artemisinin-based combination treatments during the second or third trimesters, but data on efficacy and safety in Africa were scarce. We aimed to assess whether artemether...
Main Authors: | Piola, P, Nabasumba, C, Turyakira, E, Dhorda, M, Lindegardh, N, Nyehangane, D, Snounou, G, Ashley, E, Mcgready, R, Nosten, F, Guerin, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial.
by: Piola, P, et al.
Published: (2010) -
EFFICACY AND SAFETY OF QUININE VS. ARTEMETHER-LUMEFANTRINE IN UNCOMPLICATED MALARIA DURING PREGNANCY, MBARARA, UGANDA
by: Piola, P, et al.
Published: (2009) -
Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
by: Tarning, J, et al.
Published: (2013) -
Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial.
by: Muehlenbachs, A, et al.
Published: (2012) -
Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial
by: Muehlenbachs Atis, et al.
Published: (2012-05-01)